Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CPSI NASDAQ:CRTX NASDAQ:HSTM NASDAQ:OMCL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCPSIComputer Programs and Systems$9.70$8.70▼$30.96$133.71M0.62185,176 shs534,900 shsCRTXCortexyme$1.69+2.4%$1.48$1.78▼$40.66$50.96M1.4620,672 shs143,878 shsHSTMHealthStream$25.65-1.9%$27.35$25.36▼$34.24$798.53M0.42149,187 shs229,762 shsOMCLOmnicell$29.76-4.0%$29.27$22.66▼$55.74$1.45B0.76500,803 shs742,476 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCPSIComputer Programs and Systems0.00%0.00%0.00%0.00%0.00%CRTXCortexyme+2.42%-9.14%+11.18%+59.43%+128.07%HSTMHealthStream-1.95%-4.11%-7.57%-24.71%-13.67%OMCLOmnicell-4.03%+5.27%-0.13%-4.49%+1.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCPSIComputer Programs and SystemsN/AN/AN/AN/AN/AN/AN/AN/ACRTXCortexymeN/AN/AN/AN/AN/AN/AN/AN/AHSTMHealthStream4.3688 of 5 stars2.43.01.74.82.43.31.3OMCLOmnicell3.484 of 5 stars3.35.00.00.03.11.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCPSIComputer Programs and Systems 0.00N/AN/AN/ACRTXCortexyme 0.00N/AN/AN/AHSTMHealthStream 2.80Moderate Buy$31.5022.81% UpsideOMCLOmnicell 2.57Moderate Buy$45.3352.33% UpsideCurrent Analyst Ratings BreakdownLatest CPSI, CRTX, OMCL, and HSTM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/21/2025OMCLOmnicellWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$37.00 ➝ $40.005/23/2025OMCLOmnicellPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight5/23/2025OMCLOmnicellBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$30.00 ➝ $34.005/23/2025OMCLOmnicellWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$35.00 ➝ $37.005/15/2025HSTMHealthStreamCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$30.00 ➝ $29.005/14/2025OMCLOmnicellWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$31.00 ➝ $35.005/7/2025OMCLOmnicellBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$62.00 ➝ $40.005/7/2025OMCLOmnicellWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$38.00 ➝ $31.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCPSIComputer Programs and Systems$339.43M0.00N/A1.53$12.83 per share0.00CRTXCortexymeN/AN/AN/AN/A$3.97 per shareN/AHSTMHealthStream$292.37M2.68$2.38 per share10.79$11.81 per share2.17OMCLOmnicell$1.15B1.21$2.94 per share10.13$26.98 per share1.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCPSIComputer Programs and Systems-$45.79M-$3.15N/A0.00N/A-13.49%10.33%5.23%N/ACRTXCortexyme-$89.94M-$2.97N/AN/AN/AN/A-70.96%-63.53%N/AHSTMHealthStream$20.01M$0.6340.7140.083.386.54%5.36%3.75%8/4/2025 (Confirmed)OMCLOmnicell$12.53M$0.5059.5224.009.052.01%4.27%2.44%N/ALatest CPSI, CRTX, OMCL, and HSTM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025HSTMHealthStream$0.16N/AN/AN/A$74.39 millionN/A7/31/2025Q2 2025OMCLOmnicell$0.30$0.45+$0.15$0.12$275.57 million$290.56 million5/6/2025Q1 2025OMCLOmnicell$0.16$0.26+$0.10-$0.15$260.18 million$269.67 million5/5/2025Q1 2025HSTMHealthStream$0.16$0.14-$0.02$0.14$74.93 million$73.49 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCPSIComputer Programs and SystemsN/AN/AN/AN/AN/ACRTXCortexymeN/AN/AN/AN/AN/AHSTMHealthStream$0.120.47%N/A19.05%2 YearsOMCLOmnicellN/AN/AN/AN/AN/ALatest CPSI, CRTX, OMCL, and HSTM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025HSTMHealthStreamquarterly$0.03100.37%5/19/20255/19/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCPSIComputer Programs and Systems1.052.322.31CRTXCortexymeN/A9.929.92HSTMHealthStreamN/A1.351.35OMCLOmnicell0.131.421.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCPSIComputer Programs and Systems88.64%CRTXCortexyme63.18%HSTMHealthStream69.58%OMCLOmnicell97.70%Insider OwnershipCompanyInsider OwnershipCPSIComputer Programs and Systems2.80%CRTXCortexyme27.90%HSTMHealthStream20.50%OMCLOmnicell2.52%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCPSIComputer Programs and Systems2,50014.55 million14.14 millionOptionableCRTXCortexyme5530.15 million21.74 millionNot OptionableHSTMHealthStream1,09330.53 million24.27 millionOptionableOMCLOmnicell3,67046.84 million45.66 millionOptionableCPSI, CRTX, OMCL, and HSTM HeadlinesRecent News About These CompaniesOmnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call TranscriptAugust 1 at 10:15 PM | seekingalpha.comOmnicell, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 1 at 9:54 PM | seekingalpha.comOmnicell (NASDAQ:OMCL) Shares Gap Up - Here's What HappenedAugust 1 at 12:47 PM | marketbeat.comOmnicell (NASDAQ:OMCL) Issues Q3 2025 Earnings GuidanceAugust 1 at 12:23 PM | marketbeat.comOmnicell (NASDAQ:OMCL) Releases FY 2025 Earnings GuidanceAugust 1 at 12:23 PM | marketbeat.comWall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High?August 1 at 10:56 AM | zacks.comOmnicell Shares Climb Over 2% After Second Quarter Results Surpass ExpectationsAugust 1 at 6:30 AM | msn.comQ2 2025 Omnicell Inc Earnings Call TranscriptAugust 1 at 4:20 AM | gurufocus.comGSA Capital Partners LLP Takes Position in Omnicell, Inc. (NASDAQ:OMCL)August 1 at 3:15 AM | marketbeat.comFederated Hermes Inc. Sells 41,248 Shares of Omnicell, Inc. (NASDAQ:OMCL)August 1 at 3:15 AM | marketbeat.comOmnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds ExpectationsAugust 1 at 2:29 AM | msn.comOmnicell Reports Strong Q2 2025 Financial ResultsAugust 1 at 2:26 AM | tipranks.comOmnicell Q2 Earnings: Market Ignoring The SegmentsJuly 31 at 11:49 AM | seekingalpha.comOmnicell (OMCL) Beats Q2 Earnings and Revenue EstimatesJuly 31 at 8:45 AM | zacks.comOmnicell Announces Second Quarter 2025 ResultsJuly 31 at 6:30 AM | businesswire.comEarnings To Watch: Omnicell (OMCL) Reports Q2 Results TomorrowJuly 31 at 3:51 AM | finance.yahoo.comOmnicell Q2 2025 Earnings PreviewJuly 31 at 3:51 AM | msn.comUniversal Beteiligungs und Servicegesellschaft mbH Buys New Shares in Omnicell, Inc. (NASDAQ:OMCL)July 31 at 3:22 AM | marketbeat.comOMCL vs. DOCS: Which Stock Is the Better Value Option?July 30 at 12:41 PM | zacks.comPacer Advisors Inc. Takes Position in Omnicell, Inc. (NASDAQ:OMCL)July 28, 2025 | marketbeat.comAnalysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out forJuly 24, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCPSI, CRTX, OMCL, and HSTM Company DescriptionsComputer Programs and Systems NASDAQ:CPSIComputer Programs and Systems, Inc. provides healthcare information technology solutions and services in the United States and the Caribbean nation of St. Maarten. Its software systems include patient management software that enables a hospital to identify a patient at various points in the healthcare delivery system, as well as to collect and maintain patient information throughout the process of patient care; and financial accounting software, which offers business office applications to track and coordinate information needed for managerial decision-making. The company also provides clinical software that automates record keeping and reporting for various clinical functions, including laboratory, radiology, physical therapy, respiratory care, and pharmacy; patient care applications; and enterprise applications that support its products for use in various areas of the hospital. In addition, it offers Centriq, an intuitive user interface to centralize data from various care areas that provide the end user with a tool to view past and present patient information. Further, the company provides post-acute care software systems; software application support, hardware maintenance, and education and related services; post-acute care support and maintenance services; revenue cycle management products and services, consulting and business management services, and managed information technology services; patient engagement, and encoder solutions. It serves community hospitals and physician clinics, skilled nursing, and assisted living facilities. Computer Programs and Systems, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.Cortexyme NASDAQ:CRTX$1.69 +0.04 (+2.42%) As of 07/31/2025Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.HealthStream NASDAQ:HSTM$25.65 -0.51 (-1.95%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$25.64 -0.01 (-0.04%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs. It offers hStream, a technology platform that powers a range of healthcare workforce solutions. The company provides its solutions to customers across a range of entities within the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through its direct sales teams. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.Omnicell NASDAQ:OMCL$29.76 -1.25 (-4.03%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$29.75 -0.01 (-0.03%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
